Center for Public Health, Medical University Vienna, Kinderspitalgasse 15, 1090, Vienna, Austria.
Department of Internal Medicine, University of Medical Sciences, Sabzevar, Iran.
Arch Gynecol Obstet. 2018 Aug;298(2):279-287. doi: 10.1007/s00404-018-4800-y. Epub 2018 May 24.
Asthma is the most common potentially serious medical complication in pregnancy. The purpose of this study was to determine the association between maternal asthma and a spectrum of adverse neonatal and maternal outcomes.
Events during pregnancy and birth outcome were evaluated in 34 asthmatic as well as 1569 non-asthmatic pregnant women who were enrolled in a prospective cohort study undertaken at the antenatal clinics of Mobini Hospital in Iran. The women were interviewed and classified according to clinical severity and asthma control as per GINA guidelines. Information on asthma symptoms was collected by a questionnaire as well as by spirometry and physical examination. All subjects were followed until delivery, and postpartum charts were reviewed to assess neonatal and maternal outcomes. Eosinophil cells counts were obtained and total IgE was measured by ELISA. Results were assessed by multivariate logistic regression adjusting for maternal age and parity, and for birth outcomes, for gestational diabetes, and hypertension/pre-eclampsia.
The well-known relationship between family history of asthma and asthma in pregnancy was again supported (p < 0.001). Women with asthma had more bleeding events 3 weeks or more before delivery (OR 3.30, 95% CI 1.41-7.26), more often placenta problems (OR 6.86, 95% CI 1.42-33.02), and gestational diabetes mellitus (OR 3.82, 95% CI 1.06-13.75). No significant differences between asthmatic and non-asthmatic mothers regarding duration of gestation, birthweight, low Apgar scores, or neonatal respiratory difficulties were found. Total IgE antibody levels and eosinophil counts did not differ by asthma control and severity.
Asthma in pregnancy poses some risk for pregnancy complications and adverse perinatal outcomes. Managing asthma effectively throughout pregnancy could benefit women and their babies and help to reduce the health burden associated with asthma during pregnancy.
哮喘是妊娠中最常见的潜在严重医学并发症。本研究旨在确定母体哮喘与一系列不良新生儿和产妇结局之间的关联。
在伊朗 Mobini 医院的产前诊所,对 34 名哮喘孕妇和 1569 名非哮喘孕妇进行了一项前瞻性队列研究,评估了妊娠期间的事件和分娩结局。通过问卷调查以及肺功能检查和体格检查,对孕妇进行访谈并根据 GINA 指南按临床严重程度和哮喘控制进行分类。收集哮喘症状信息。所有受试者均随访至分娩,并查阅产后图表以评估新生儿和产妇结局。通过 ELISA 测定嗜酸性粒细胞计数和总 IgE。结果通过多元逻辑回归进行评估,调整了母亲的年龄和产次,以及分娩结局、妊娠糖尿病和高血压/子痫前期。
再次证实了哮喘家族史与妊娠哮喘之间的已知关系(p<0.001)。有哮喘的女性在分娩前 3 周或更长时间出血事件更多(OR 3.30,95%CI 1.41-7.26),胎盘问题更常见(OR 6.86,95%CI 1.42-33.02),妊娠糖尿病(OR 3.82,95%CI 1.06-13.75)。哮喘和非哮喘母亲在妊娠持续时间、出生体重、低 Apgar 评分或新生儿呼吸窘迫方面无显著差异。哮喘控制和严重程度对总 IgE 抗体水平和嗜酸性粒细胞计数无影响。
妊娠哮喘对妊娠并发症和不良围产期结局构成一定风险。在整个妊娠期间有效管理哮喘可使妇女及其婴儿受益,并有助于减轻与妊娠相关的哮喘的健康负担。